Lifevantage Corp (LFVN)
Pharmaceutical Preparations · Healthcare · $76M
Intrinsic Value (Consensus)
$16.63
Current Price
$6.04
Margin of Safety
+175.3%
175.3% Below Intrinsic Value
Value: $17
Price: $6
Valuation Model Estimates
Current Price: $6.04
DCF (Discounted Cash Flow)
$39.08
Graham Number
$6.81
Earnings Power Value
$7.28
Relative Value (P/E)
$15.00
Dividend Discount Model
$15.00
Consensus Value
$16.63
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
81
Profitability
25/25
Strength
15/25
Valuation
22/25
Growth
19/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 116%
Strong profitability — ROE of 28% (above 20% is excellent)
Strong earnings growth (20% YoY)
High free cash flow yield (13.8%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.75
- EPS (Forward)
- $0.90
- Book Value
- $2.75
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 28.3%
- Debt/Equity
- 116%
- Revenue Growth
- 14.2%
- Earnings Growth
- 20.0%
- Dividend Yield
- 0.3%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance